Statistics for Legend Biotech (id:7229 LEGN)

Valuation metrics

Market cap

7.35B

Enterprise value

13.77B

Trailing P/E (ttm)

-13.96

Forward P/E

-59.54

PEG ratio

-59.54

Price/Sales (ttm)

14.13

Price/Book (mrq)

6.56

Enterprise Value/Revenue

26.47

Enterprise Value/EBITDA

-40.43

Overview

Shares outstanding

184.29M

Float

162.80M

Shares short

15.86M

% Held by insiders

0.01%

% Held by institutions

0.53%

Average volume (10 days)

1.88M

Average volume (90 days)

Price summary

52-Week low

36.92

52-Week high

70.13

52-Week change

-50.37%

Beta

0.11

50-Day moving average

46.49

200-Day moving average

51.36

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-66.92%

Operating margin

-43.92%

Operational effectiveness

Return on assets

-12.28%

Return on equity

-28.35%

Income statement

Revenue (ttm)

2.85

Revenue per share (ttm)

2.85

Quarterly revenue growth (yoy)

Gross profit (ttm)

140.93M

EBITDA

-340,560,000.00

Net income to common (ttm)

-348,128,000.00

Diluted EPS (ttm)

-1.56

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

1.21B

Total cash per share (mrq)

3.30

Total debt (mrq)

346.59M

Total Debt/Equity (mrq)

31.05

Current ratio (mrq)

498.40%

Book value per share (mrq)

6.08

Cash flow

Cash flow statement

-157,600,000.00

Levered free cash flow (LFCF)

-120,406,752.00